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T-ALL accounts for 15% of childhood leukemias and approximately 60% of 
patients overexpress TAL1.  TAL1/SCL encodes a transcription factor that regulates 
hematopoiesis by dimerizing with additional transcription factors including E12, E47, 
and GATA-1.  TAL1 has also been found to repress expression of NF-κB1, potentially 
promoting formation of an NF-κB p65/c-Rel heterodimer that encourages cell survival by 
up-regulating IAPs and IκB.  However, the correlation between TAL1 and p65/c-Rel 
expression and their effects on downstream targets like IKK, IκB, and other anti-
apoptotic proteins is poorly understood.  Jurkat cells, expressing TAL1, were treated 
with TNFα and/or etoposide to induce apoptosis and experiments were performed to 
assess the expression of proteins of interest.  Caspase-8 activity assays were also 
performed to help delineate the apoptotic signal present in these cells.  Determining if 
interactions between TAL1, NF-κB, and other downstream targets help promote 
apoptotic resistance will further research into better, more targeted treatments for T-
ALL. 